Pre-Transplantation Strategies for Infectious Disease Mitigation and Prevention

被引:0
|
作者
Heald-Sargent, Taylor [1 ,6 ]
Michaels, Marian G. [2 ]
Ardura, Monica, I [3 ,4 ,5 ]
机构
[1] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp, Dept Pediat, Div Infect Dis, Chicago, IL USA
[2] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Dept Pediat, Div Pediat Infect Dis,Sch Med, Pittsburgh, PA USA
[3] Ohio Univ, Coll Med, Div Pediat Infect Dis, Columbus, OH USA
[4] Ohio Univ, Coll Med, Host Def Program, Nationwide Childrens Hosp, Columbus, OH USA
[5] Ohio Univ, Coll Med, Dept Pediat, Columbus, OH USA
[6] 225 E Chicago Ave,Box 20, Chicago, IL 60611 USA
关键词
hematopoietic cell transplantation; pediatric; pre-transplant evaluation; prevention; safe living; screening; solid organ transplantation; vaccination; HEMATOPOIETIC-CELL TRANSPLANTATION; HEPATITIS-B-VIRUS; CYTOMEGALOVIRUS-INFECTION; RECIPIENTS; PROPHYLAXIS; GUIDELINES; THERAPY; TOXOPLASMOSIS; IMMUNIZATION; VACCINATION;
D O I
10.1093/jpids/piad075
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Pediatric Infectious Disease (ID) clinicians play a critical role in helping prevent and mitigate infectious risks in children peri- and post-transplantation. Prevention starts during the pre-transplant evaluation and persists throughout the solid organ transplant and hematopoietic cell transplant continuum. The pre-transplant evaluation is an opportunity to screen for latent infections, plan preventative strategies, optimize immunizations, and discuss risk mitigation practices. An ideal pre-transplant evaluation establishes a relationship with the family that further promotes post-transplant infectious risk reduction. This manuscript builds on shared pediatric ID prevention strategies, introduces updated ID testing recommendations for transplant donors/candidates, highlights emerging data, and identifies ongoing knowledge gaps that are potential areas of research.
引用
收藏
页码:S3 / S13
页数:11
相关论文
共 50 条
  • [21] Impact of pre-transplantation minimal residual disease (MRD) on the outcome of Allogeneic hematopoietic stem cell transplantation for acute leukemia
    Shen, Xing
    Pan, Jing
    Qi, Chenchen
    Feng, Yuan
    Wu, Hanxin
    Qian, Sixuan
    Lu, Hua
    Chen, Lijuan
    Li, Jianyong
    Miao, Kourong
    Qiu, Hairong
    Zhu, Han
    HEMATOLOGY, 2021, 26 (01) : 295 - 300
  • [22] Natural history of kidney damage in rat in pre-transplantation period
    Marakhonov, A.
    Filatova, A.
    Zamkova, M.
    Gus'kova, A.
    Skoblov, M.
    Skvortsov, A.
    Reznik, A.
    Reznik, O.
    Baranova, A.
    FEBS JOURNAL, 2013, 280 : 241 - 241
  • [23] INSIGNIFICANT TUMOR BED EFFECT AFTER PRE-TRANSPLANTATION HYPERTHERMIA
    URANO, M
    CUNNINGHAM, M
    CANCER RESEARCH, 1980, 40 (01) : 26 - 28
  • [24] CAUSES OF CHRONIC RENAL-INSUFFICIENCY IN PRE-TRANSPLANTATION NEPHRECTOMY
    VELAZQUEZFORERO, F
    ZURITA, R
    CASTELLANOS, J
    PATOLOGIA-MEXICO CITY, 1979, 17 (02): : 172 - 172
  • [25] The Utility of Screening Computed Tomography in Renal Pre-Transplantation Candidates
    Patel, Parth
    Collins, Joseph
    Abu Alhana, Farouk
    Jaara, Eyad
    Mitro, Graham
    Orti, Jorge
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 52 - 52
  • [26] Association Between Dyspnea and Severity of Liver Disease in Patients in the Pre-transplantation Period-A Pilot Study
    da Silva, A. G. Monte
    deA Roza Aguiar, B.
    Chiavegato, L. D.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (07) : 2328 - 2332
  • [27] STRATEGIES FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER MARROW TRANSPLANTATION
    GOODRICH, JM
    BOECKH, M
    BOWDEN, R
    CLINICAL INFECTIOUS DISEASES, 1994, 19 (02) : 287 - 298
  • [28] Association between Pre-Transplantation Cognitive Impairment and Early Post-Transplantation Outcomes
    Ahmed, W. S.
    Chowdhury, N.
    Mathur, S.
    Abbey, S.
    Ross, H. J.
    Singer, L. G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S364 - S364
  • [29] Liver transplantation in alcoholic patients: Importance of pre-transplantation variables in predicting recidivism among various liver disease subgroups.
    Hillebrand, DJ
    Voigt, M
    LaBrecque, DR
    Tarara, D
    Vorheis, M
    McKeone, K
    Yates, W
    Wu, Y
    Corwin, C
    Fabrega, A
    Martin, M
    HEPATOLOGY, 1997, 26 (04) : 1580 - 1580
  • [30] Transfusion therapy during liver transplantation is dependent on the pre-transplantation platelet count.
    Martin, TG
    Shuman, MA
    BLOOD, 1997, 90 (10) : 3316 - 3316